
NORTH CHICAGO, Illinois — Walgreens Boots Alliance Inc (WBA.O), the owner of the Walgreens drugstore chain, reported weaker-than-expected quarterly results on Friday and gave a disappointing forecast, sending its shares down 6%.
The company said net income fell to $380 million, or $1.08 per share, in the quarter ended May 31, from $669 million, or $1.89 per share, a year earlier. Analysts on average had expected earnings of $1.10 per share, according to Refinitiv data.
Walgreens said U.S. pharmacy sales declined 3.9% due to lower sales of generic drugs and a shift in business from high-margin long-term care to lower-margin retail. Same-store sales in the U.S. fell 2.3%.
The company's shares were down 6% at $44.60 in morning trading.
Walgreens also said it expects full-year earnings to be between $4.30 and $4.45 per share, below analysts' average estimate of $4.47 per share.
The results come as Walgreens continues to face pressure from competition in the pharmacy sector, particularly from Amazon.com Inc (AMZN.O), which has been expanding its own pharmacy services.
Walgreens Chairman and Chief Executive Officer Doug McMillon said the company is "executing against our strategic priorities" but acknowledged that "the macro environment remains challenging." (Reporting by Sanjana Sastry in Boston; Editing by Will Dunham and Nick Zieminski)
崾 complains of unsatisfactory quarterly performance and lowered its outlook, causing its shares to drop 6%.
Walgreens reported a net income of $380 million, or $1.08 per share, for the quarter ended May 31, down from $669 million, or $1.89 per share, in the same period a year earlier.
The company attributed the decline to lower U.S. pharmacy sales, which fell 3.9% due to decreased sales of generic drugs and a shift from high-margin long-term care to lower-margin retail. Same-store sales in the U.S. decreased by 2.3%.
Walgreens also announced an outlook for full-year earnings between $4.30 and $4.45 per share, below the analysts' average estimate of $4.47 per share.
The company faces ongoing pressure from competitors like Amazon, which has been expanding its pharmacy services.
Walgreens Chairman and CEO Doug McMillon stated, "We are executing against our strategic priorities," but acknowledged the challenging macro environment.
Shares of Walgreens were trading down 6% at $44.60 in morning trading.
Walgreens #QuarterlyResults #EarningsReport #StockMarket #RetailPerformance
骑手缴纳社保,外卖会变贵吗?网友:这是我最关心的
每日经济新闻
马斯克狂赞的“地球最聪明AI”,背后竟有1/3华人团队撑腰!
大众新闻
Deepseek测出理想伴侣仅存个位数?别慌!赛博月老只懂数据,不懂爱情
纵览新闻
从“按月计”到“次日达”,医保基金即时结算有哪些好处?
央视新闻
饿了么:2023年起已启动骑手社保缴纳试点
九派新闻
义乌老板利用DeepSeek卖空小商品:只需对镜头说“12345”就可以了
大河报
鳌太线失联10天亲历者:铺树叶裸睡一晚,把牙膏当糖吃
潇湘晨报
被控受贿3501万余元 中国石油原董事长王宜林受贿案一审开庭
央视新闻客户端
菲律宾飞机非法闯入中国南沙岛礁附近空域,南部战区发声
“南部战区”微信公众号
长沙一小区楼顶被种出茂密“丛林”,居民担心安全!城管:屋顶有产权,会上门查看
潇湘晨报